article thumbnail

B2B Sales Consulting for Medical Sales: A Comprehensive Guide

Rep-Lite

B2B sales consulting for medical sales is a specialized service that helps healthcare organizations navigate the unique challenges of B2B transactions within the healthcare industry. What is B2B Sales Consulting? B2B sales consulting involves working with businesses to enhance their sales strategies and operations in a B2B context.

article thumbnail

The Ethical Challenges for Pharmaceutical Marketers in Using AI to Write Marketing Copy or Creative

Pharma Marketing Network

While AI can be a powerful tool for creating effective marketing campaigns, it also poses significant ethical challenges. One of the main ethical concerns with using AI in pharmaceutical marketing is the potential for the technology to perpetuate biases and discrimination. AI Ethics: The Importance of Fairness.” .

Ethics 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Successful Drug Launches in a Digital-Forward Market: Q&A with Bridget Seay, Executive Director of Customer Experience & Commercial Consulting, epocrates

PharmExec

Bridget Seay of epocrates delves into drug launches in a digital-forward market, exploring how pharmaceutical companies can navigate complex patient journeys, strike a balance between traditional and digital marketing tactics, and ethically engage with healthcare professionals and empowered patients amidst ever-changing regulations.

Ethics 98
article thumbnail

From skepticism to strategy: How AI is transforming the IP practice

Clarivate

What does responsible and ethical AI look like? Keep reading for insights shared by Clarivate experts, Arun Hill, Senior Consultant Intellectual Property, Peter Keyngnaert, Director, Data Science and Phil Arvanitis, Practice Director, Intellectual Property Consulting. What do IP practitioners need to know about the AI basics?

Ethics 59
article thumbnail

Unlocking the potential of AI and machine learning for the life sciences

Clarivate

“Because of this speed and the rate of learning, governments won’t have enough money [to pay for all the new therapeutics it produces],” said Darrin Baines, Global Head of Health Economics, Life Sciences Consulting Services at Clarivate. They have no ethics. They’re wonderful for compiling data but they have no ethics.

Ethics 52
article thumbnail

MHRA regulation overhaul: new scheme for lowest-risk UK clinical trials

European Pharmaceutical Review

The new Notification Scheme is based on that outlined in the MHRA’s clinical trials consultation, which was endorsed by 74 percent of those who responded. An opinion from a research ethics committee will remain a requirement for eligible trials, the agency added. Certain criteria are applicable to the new scheme.

Ethics 94
article thumbnail

European regulators prepare for AI in pharma

European Pharmaceutical Review

Work has already begun with the ongoing public consultation on the AI reflection paper, open until the end of 2023. Guidance, policy and product support : Actions focus on continuous support to products in development as well as the development and evaluation of appropriate guidance for the use of AI in the lifecycle of a medicine.

Pharma 92